Clinical characteristics of patients with prostate cancer bone metastases obtained at orthopedic surgery.

Continuous values are given as median (min–max values).aCastration-resistant patients had disease progression after long-term androgen deprivation therapy.bIncludes surgical ablation, LHRH/GNRH agonist therapy, and therapy with anti-androgens (casodex, flutamide), but specifically no anti-androgens at the time for orthopedic surgery.cCastration therapy as stated above and anti-androgen therapy (casodex) at the time for orthopedic surgery.dRadiation towards operation site.eThe time between date of operation and the latest follow-up examination or death.连续型数据以中位数（最小值-最大值）的形式给出。 a. 去势抵抗性患者在长期雄激素剥夺治疗（androgen deprivation therapy）后出现疾病进展。 b. 涵盖手术去势、黄体生成素释放激素（LHRH）/促性腺激素释放激素（GNRH）激动剂治疗，以及抗雄激素治疗（比卡鲁胺（casodex）、氟他胺（flutamide）），但骨科手术期间未使用抗雄激素药物。 c. 骨科手术期间采用前述去势治疗联合抗雄激素治疗（比卡鲁胺（casodex））。 d. 手术区域放射治疗。 e. 手术日期至末次随访检查或死亡之间的间隔时长。